Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Association between cardiovascular and cognitive health among older Indigenous Africans: Data from an urban Nigerian settlement participating in the VALIANT study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Correlates of hand grip strength in a cohort of older Nigerian Africans: Findings from the population-based VALIANT project.

The Journal of frailty & aging·2025
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Tolulope O Akinyemi1

  • 1Lead City University, Ibadan, Oyo, Nigeria.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

这项研究探讨了尼日利亚成年人的阿尔茨海默病生物标志物,确定了与炎症和神经退行相关的新型蛋白质. 这些发现强调了在阿尔茨海默病和相关痴呆症的生物标志物研究中需要多样化的人口.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 基因组学就是基因组学.

背景情况:

  • 阿尔茨海默病和相关痴呆症 (ADRD) 生物标志物研究在非洲刚刚开始,全球北方人口的数据有限.
  • 非洲的风险因素和并发症不同,需要对不同人群进行研究,以验证生物标志物的实用性.
  • 这项研究使用先进的多重技术研究了尼日利亚队列中的血生物标志物.

研究的目的:

  • 在一个大型的,基于社区的老年尼日利亚人的队列中调查血生物标志物表达.
  • 使用单分子阵列 (SIMOA) 和核酸链接免疫三明治测试 (NULISA) 技术进行生物标志物分析.
  • 在非洲人口中识别与阿尔茨海默氏症病理学相关的新型蛋白质特征.

主要方法:

  • 分析了来自VALIANT队列的947名尼日利亚老年人 (约鲁巴族) 的血样本.
  • 使用SIMOA和NULISAseq平台测量血生物标记物 (Aβ40,Aβ42,NfL,GFAP,p-Tau217) 和新型蛋白质特征.
  • 采用线性模型,根据粉样蛋白 (Aβ) 状态和认知功能来识别差异丰富的蛋白质 (DAP).

主要成果:

  • 血p-tau217,GFAP和NfL水平在不同组中逐渐增加.
  • 轻度认知障碍 (MCI) 的Aβ42/Aβ40比率高于认知不受损 (CU) 或痴呆症组.
  • 在Aβ阳性和Aβ阴性组之间确定了50多个DAP;在Aβ阳性组内的认知障碍个体中,GFAP,POSTN和IGFBP7的升高.

结论:

  • 初步发现表明DAP与炎症,神经退行以及在存在Aβ病理时的粉样蛋白/粉样蛋白病理有关.
  • 结果与阿尔茨海默病生物标志物的现有知识保持一致并扩展.
  • 进一步的分析将探索与当前科学理解的独特和共同的特征.